Report cover image

Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Jul 16, 2024
Length 69 Pages
SKU # GBDT19099834

Description

Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Vitreo Retinal Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vitreo retinal surgical devices are used for surgical procedures that treat eye problems involving the retina, macula, and vitreous fluid.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Vitreo Retinal Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vitreo Retinal Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

69 Pages
    • Vitreo Retinal Surgery Devices Overview
    • Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
    • Vitreo Retinal Surgery Devices - Pipeline Products by Territory
    • Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path
    • Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date
    • Vitreo Retinal Surgery Devices - Ongoing Clinical Trials
    • Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development
    • Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
    • ABVC BioPharma Inc Company Overview
    • AcuSurgical SAS Company Overview
    • Al.chi.mi.a. Srl Company Overview
    • Alcon Inc Company Overview
    • Bausch & Lomb Inc Company Overview
    • Beaver-Visitec International Inc Company Overview
    • Boston College Company Overview
    • Cambridge Polymer Group Inc Company Overview
    • Carnegie Mellon University Company Overview
    • Duke University Company Overview
    • Hangzhou Xiran Medical Equipment Technology Co Ltd Company Overview
    • Johns Hopkins University Company Overview
    • Medisse BV (Inactive) Company Overview
    • RetinaSense Company Overview
    • Synergetics USA, Inc. (Inactive) Company Overview
    • The Chinese University of Hong Kong Company Overview
    • Tupai (Beijing) Medical Technology Co Ltd Company Overview
    • University of Kansas Company Overview
    • University of Minnesota Company Overview
    • May 13, 2024: Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
    • Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
    • Feb 27, 2024: Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
    • Feb 12, 2024: ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
    • Oct 26, 2023: Pixium Vision Announces its Financial Results for H1 2023 and Provides Update
    • Oct 02, 2023: Zeiss and Boehringer Ingelheim Are Working Together on the Early Detection of Eye Diseases and the Prevention of Vision Loss
    • Aug 23, 2023: ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study
    • Aug 15, 2023: Alcon Reports Second Quarter 2023 Results
    • Aug 03, 2023: ABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration
    • Jul 13, 2023: Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.